French Alternative Energies and Atomic Energy Commission
Gif-sur-yvette cedex, PO: 91191 (Undefined)
Gene therapy approach.
Rodent, non human primates in BCL1/BCL2/BCL3, zebrafish models for all main diseases affecting the central and peripheral nervous system.
Operating under BCL1, BCL2 and BCL3.
Rodents and non-human primates.
MRI, EEG, MEG, PET operating under BCL1/BCL2/BCL3 conditions; pre clinical and clinical expertise.
Lentiviral vector and AAV production (9 BCL3 laboratories).
2μPET scanner operating under either BCL2 or BCL3 conditions for rodent/ non-human primate iamging; 5 PET and 4 γ (gamma) cameras; 2 scanners for human imaging; 1μPET for small animal imaging.
Operating under BCL1, BCL2 and BCL3 conditions.
400 m2 laboratory dedicated to behavioural testing (motor and cognitive testing) under BCL2 and BCL3 conditions.
Confocal microscopy, bi-photonic microscopy, lightsheet, spinning-disk...
Brain Bank; DNA and cell bank; MS DNA bank; CNS tumor bank.
1.5T, 2x3T, 7T, 11.7T MRI systems for clinical purposes; 7T system for rodent and non-human primate imaging; 17.65T + 7T MRI system operating under BCL1/BCL2/BCL3 conditions for rodent and non-human primate imaging; 9.4T MRI system operating under BCL1/BCL2 conditions for rodents.
Includes a cyclotron.
With the following capacity: 1000 rodents under BCL1/BCL2 conditions, 1000 rodents under BCL3, 400 non-human primates under BCL1/BCL2 conditions. Zebrafish and xenopus housing.